The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the ...

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...

Endocytosis and recycling control the uptake and retrieval of various materials in eukaryotic cells. Mammalian cells have ...

The significant rise in the use of biopharmaceutical and large molecule therapeutics over recent years has made peptides and proteins popular drug discovery targets for the pharmaceutical and ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

Forbes spotlights entrepreneurs, scientists, philanthropists, corporate leaders and policymakers focused on sustainable ...

Readers raved about 50 local spots, including a Mexican street food restaurant, a cantina, a taquira, food trucks and ...

Lisa Ferrara, Ph.D., brings over 30 years of experience in orthopaedic medical device innovation and regulatory strategy in the USA·       Dr Ferrara will play a pivotal role in advancing Renovos’ ...

A study led by the Department of Energy's Oak Ridge National Laboratory details how artificial intelligence researchers have ...